Baiji Shenzhou: baizean's new indication for esophageal squamous cell carcinoma is accepted in China
According to the official account of WeChat, China announced today that the NMPA drug control center (CDE) had accepted its anti PD-1 antibody, baichai. ®（ Tirizumab injection is a new indication for the treatment of locally advanced or metastatic esophageal squamous cell carcinoma (ESCC) patients who have previously received first-line standard chemotherapy.
Briefing Jun 10, 2022 09:48 PM
Singaporean Prime Minister Lee Hsien Loong meets with weifenghe
In-depth
Briefing Jun 10, 2022 07:17 PM
Baiji Shenzhou PD-1 monoclonal antibody baizean ® The ninth indication was obtained and the first-line treatment for nasopharyngeal carcinoma was approved
Briefing Apr 28, 2022 09:59 AM
A new breakthrough in the first-line treatment of advanced esophageal cancer: PD-1 monoclonal antibody baizean ® Global phase 3 clinical trials reached the primary end point
Dec 11, 2023 08:49 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Briefing Mar 11, 2022 10:59 AM
· Financials
Baiji China: the tentative list is a normal step and will not affect the listing of the company on NASDAQ
Briefing Feb 25, 2022 08:48 PM
Ministry of agriculture and rural areas: implement the ten-year fishing ban on the Yangtze River in 2022 and promote the conservation of aquatic biological resources
Briefing Feb 15, 2022 06:19 AM
· Automotive
Hillhouse Q4 position: increased holdings of ideal automobile and Xiaopeng automobile sea, and ideal automobile rushed into the top ten
Briefing Feb 02, 2022 12:50 AM
Popular Chinese concept stocks continued to rise today, and iqiyi, douyu and litchi rose more than 8%
Consumer Staples
MissFresh Considering US IPO
On the evening of April 7, according to Bloomberg, the fresh food distribution platform backed by Tencent was discussing with consulting agencies about preparing to go public. The IPO may be carried out as early as this year. Although the negotiation is still at the immature stage, the planned financing amount is at least USD 500 million – but might stretch higher, to USD 1 billion.
Apr 08, 2021 10:25 AM
Briefing Jan 31, 2022 10:29 AM
· Healthcare
Hong Kong Pharmaceutical stocks generally rose, with Cinda biology up nearly 6%
See more
Read next
Insight
In-depth
Consumer Staples · Analysis
Chinese Cuisine Brand YGF Malatang Ventures into Brazil
Apr 23, 2024 02:21 PM